Amblyopia Severity Predicts Fixation Dysfunction Independent of Nystagmus and Foveation Disruption in Fusion Maldevelopment Nystagmus
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.8.62 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Hanieh Agharazi and 4 co-authors. Institution: Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States. Major MEDLINE topics: Amblyopia, Fixation, Ocular, Nystagmus, Pathologic. 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: RRD VA.
Abstract (original language)
Purpose
Fixation instability in amblyopia, with or without strabismus, reflects abnormalities in physiologic fixational eye movements (FEMs) and, in some individuals, fusion maldevelopment nystagmus (FMN), a pathognomonic marker of early binocular disruption. We quantified time and frequency domain FEM characteristics across amblyopic and strabismic cohorts to determine how amblyopia severity, strabismus, and FMN influence FEM abnormalities, binocular disconjugacy, and foveation across viewing conditions.
Methods
FEMs were recorded under binocular and monocular viewing in controls (n = 64) and patients with anisometropic amblyopia (n = 30), strabismic/mixed amblyopia (n = 40), and strabismus without amblyopia (n = 27) using high-resolution video-oculography. Time domain FEM metrics (amplitude, velocity, and amplitude disconjugacy), foveation times, and frequency domain analyses were performed. Linear mixed-effects models assessed the effects of amblyopia subtype and severity, strabismus, and nystagmus on eye-specific FEM characteristics across viewing conditions.
Results
Fast FEM amplitudes correlated strongly with visual acuity deficits, independent of amblyopia subtype and FMN presence. Greater interocular differences in viewing-eye fast FEM amplitude and slow FEM velocity were observed in amblyopic patients, indicating a sensory rather than alignment-driven effect. In patients with FMN and moderate to severe amblyopia, amblyopic-eye viewing was associated with reduced foveation time and increased spectral power, along with increased fast FEM amplitude disconjugacy, whereas these differences and disconjugacies were attenuated in other groups.
Conclusions
Time and frequency domain FEM analyses reveal that fixation abnormalities are a marker of amblyopia. FEM and nystagmus metrics thus serve as sensitive, quantitative biomarkers of binocular sensorimotor integrity and may support objective detection and monitoring of amblyopia.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States.
- School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States.
- Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
- Department of Neurology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States.
- Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio, United States.
Funding
- RRD VA
Cite
APA
Agharazi, H., Raju, P., Rakshit, A., Shaikh, A., & Ghasia, F. (2026). Amblyopia Severity Predicts Fixation Dysfunction Independent of Nystagmus and Foveation Disruption in Fusion Maldevelopment Nystagmus. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.8.62
Vancouver
Agharazi H, Raju P, Rakshit A, Shaikh A, Ghasia F. Amblyopia Severity Predicts Fixation Dysfunction Independent of Nystagmus and Foveation Disruption in Fusion Maldevelopment Nystagmus. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.8.62
BibTeX
@article{Agharazi2026,
author = {Agharazi, Hanieh and Raju, Priya and Rakshit, Archayeeta and Shaikh, Aasef and Ghasia, Fatema},
title = {Amblyopia Severity Predicts Fixation Dysfunction Independent of Nystagmus and Foveation Disruption in Fusion Maldevelopment Nystagmus},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.8.62}
}
EUVIMED